News By Tag
News By Location
Follow on Google News
United States Liquid Biopsy Market to Experience 6-8% CAGR Growth by 2028
United States Liquid Biopsy Market to Experience 6-8% CAGR Growth by 2028: Rising Cancer Rates and Growing Demand for Minimally Invasive Procedures
By: Makreo Research And Consulting
Changing Treatment Methods: The way cancer is treated has fundamentally changed as a result of liquid biopsy, a rapid, painless process that provides a superior alternative to invasive surgical biopsies. It helps the medical professionals discover a wealth of knowledge about the tumour through a little sample.
The non-invasiveness of liquid biopsy is the main element influencing its great demand among medical professionals. It is less invasive, more convenient, and quicker for patients than other treatments because just 5 milliliters of blood are required.
It is anticipated that circular tumour cells will remain dominant even in the coming years. The escalating cancer rate and the development of ctDNA-based liquid biopsy analysis, which can assess prognosis and tumour progression, are driving the market demand for Circulating tumour DNA (ctDNA).
A detailed study has been conducted by Makreo Research titled "United States Liquid Biopsy Market Revenue and Forecast to 2028" that assess the present adoption rate of the newly introduced biopsy technique in the US market and also highlights future expected growth.
Report covers below areas:
To know more about publication checkout our report:-
United States Liquid Biopsy Market Revenue and Forecast to 2028 (https://www.makreo.com/
Contact us on-
Makreo Research and Consulting
Send us query at firstname.lastname@example.org
Related Press Release:-
Account Email Address Account Phone Number Disclaimer Report Abuse
Page Updated Last on: Jan 27, 2023